On September 2, 2021 Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, reported it will participate in three upcoming conferences (Press release, Delcath Systems, SEP 2, 2021, View Source [SID1234595224]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 23rd Annual Global Investment Conference: September 13th to 15th, 2021

Presentation Date and Time: On-demand beginning 9/13/2021 at 7:00 AM (ET)
Webcast: View Source
Management will also host 1×1 investor meetings during the conference.
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit: September 20-23

Presentation Date and Time: 9/21/2021 12:25 PM (ET)
Webcast: View Source
Management will also host 1×1 investor meetings during the conference.
Cantor Fitzgerald Healthcare Conference: September 27th to 30th, 2021

Presentation Date and Time: 9/29/2021 4:40 PM (ET)
Webcast: View Source
Management will also host 1×1 investor meetings during the conference.
To learn more or to schedule a one-on-one meeting with management, please contact your conference representative or [email protected].